Bionano Genomics, Inc. revised revenue guidance for the third quarter ended September 30, 2023. Revenues for the third quarter of 2023 are expected to be in the range of $9.1 million to $9.3 million, an estimated increase of 26% to 29% compared to the third quarter of 2022, which would be at the higher end of revenue guidance of $8.8 million to $9.2 million provided in August 2023.